Ann Lab Med.  2017 Jul;37(4):343-345. 10.3343/alm.2017.37.4.343.

Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines

• Kim TS
• Chung JI
• Noh GH
• Hwang H

• KMID: 2376794
• DOI: http://doi.org/10.3343/alm.2017.37.4.343

Abstract

No abstract available.

MeSH Terms

Cell Line*
Urinary Bladder Neoplasms*
Urinary Bladder*

Reference

1. Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004; 171:2186–2190. quiz 2435. PMID: 15126782.

2. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013; 63:1059–1071. PMID: 23540953.

3. O'Brien T, Ray E, Chatterton K, Khan MS, Chandra A, Thomas K. Prospective randomised trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumor (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. BJU Int. 2013; 1096–1104. PMID: 24053153.

4. van Lingen AV, Witjes JA. Current intravesical therapy for non-muscle invasive bladder cancer. Expert Opin Biol Ther. 2013; 13:1371–1385. PMID: 23957696.

5. Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, et al. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer. Int Urol Nephrol. 2015; 47:1509–1514. PMID: 26149637.

6. Hayne D, Stockler M, McCombie SP, Chalasani V, Long A, Martin A, et al. BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301). BMC Cancer. 2015; 15:432. PMID: 26014129.

7. Burstein HJ, Mangu PB, Somerfield MR, Schrag D, Samson D, Holt L, et al. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol. 2011; 29:3328–3330. PMID: 21788567.